Metraipolis › archive › dc_ea2aa7be68e6

National Poison Center Trends in GLP-1 Receptor Agonist Exposures Following FDA Approval for Weight Loss — Europe PMC PMID:41634285

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41634285
DOI
10.1007/s13181-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-06T03:43:55.864Z
SHA-256 of the archived text
d8c27bba884fd5b302525ac8b15ca012f836a5c675fc300775c272da2c315d21
Stable URL of this page
https://metraipolis.com/documento/dc_ea2aa7be68e6

How to cite

National Poison Center Trends in GLP-1 Receptor Agonist Exposures Following FDA Approval for Weight Loss — Europe PMC PMID:41634285 — Europe PMC (en), https://europepmc.org/article/MED/41634285 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea2aa7be68e6 (Metraipolis archive dc_ea2aa7be68e6, sha256 d8c27bba884fd5b302525ac8b15ca012f836a5c675fc300775c272da2c315d21)
BibTeX
@misc{dcea2aa7be68e6,
  title = {National Poison Center Trends in GLP-1 Receptor Agonist Exposures Following FDA Approval for Weight Loss — Europe PMC PMID:41634285},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41634285},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea2aa7be68e6; sha256 d8c27bba884fd5b302525ac8b15ca012f836a5c675fc300775c272da2c315d21},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41634285. Agents can read the archived copy with the MCP tool read_document.